Durvalumab in NSCLC: latest evidence and clinical potential - Nerea Muñoz-Unceta, Isabel Burgueño, Elizabeth Jiménez, Luis Paz-Ares, 2018
PD-L1 PET/CT Imaging with Radiolabeled Durvalumab in Patients with Advanced-Stage Non–Small Cell Lung Cancer | Journal of Nuclear Medicine
Single Technology Appraisal Durvalumab for maintenance treatment of unresectable non-small-cell lung cancer after platinum-based
The Evolving Role of PD-L1 Inhibition in Non-Small Cell Lung Cancer: A Review of Durvalumab and Avelumab. - Abstract - Europe PMC
Durvalumab in NSCLC: latest evidence and clinical potential - Nerea Muñoz-Unceta, Isabel Burgueño, Elizabeth Jiménez, Luis Paz-Ares, 2018
small_cell_lung_lead.jpg
Frontiers | A Phase II Trial of Adjuvant Durvalumab Following Trimodality Therapy for Locally Advanced Esophageal and Gastroesophageal Junction Adenocarcinoma: A Big Ten Cancer Research Consortium Study
Simulated PK profiles of durvalumab following weight-based dosing... | Download Scientific Diagram
Durvalumab in non-small-cell lung cancer patients: current developments | Future Oncology
Cancers | Free Full-Text | TremelImumab and Durvalumab Combination for the Non-OperatIve Management (NOM) of Microsatellite InstabiliTY (MSI)-High Resectable Gastric or Gastroesophageal Junction Cancer: The Multicentre, Single-Arm, Multi-Cohort, Phase ...
IMFINZI, INN-durvalumab
Durvalumab in non-small-cell lung cancer patients: current developments | Future Oncology
4179-NSCLC locally advanced durvalumab (flat dosing) following chemoradiation | eviQ
Dr. Sonpavde on Fixed-Dose Durvalumab and Tremelimumab Study in Urothelial Carcinoma
Durvalumab in non-small-cell lung cancer patients: current developments | Future Oncology
IMFINZI, INN-durvalumab
Single Technology Appraisal Durvalumab for maintenance treatment of unresectable non-small-cell lung cancer after platinum-based
4179-NSCLC locally advanced durvalumab (flat dosing) following chemoradiation | eviQ
Study Design. Dur, durvalumab; MTD, maximum tolerated dose; NSCLC,... | Download Scientific Diagram
Antitumor activity of durvalumab per blinded independent central review... | Download Scientific Diagram
IMFINZI, INN-durvalumab
Alternative dosing strategies for immune checkpoint inhibitors to improve cost-effectiveness: a special focus on nivolumab and pembrolizumab - The Lancet Oncology
Easy Durvalumab Dosing - 2 MCQs | The Discreet Pharmacist
![Automated radiosynthesis of [89Zr]Zr-DFOSq-Durvalumab for imaging of PD-L1 expressing tumours in vivo - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0969805123000380-ga1.jpg "Automated radiosynthesis of [89Zr]Zr-DFOSq-Durvalumab for imaging of PD-L1 expressing tumours in vivo - ScienceDirect")
Automated radiosynthesis of [89Zr]Zr-DFOSq-Durvalumab for imaging of PD-L1 expressing tumours in vivo - ScienceDirect
